A prospective cohort study of asthma and COPD overlap in Japanese patients with COPD according to the diagnostic criteria of The Japanese Respiratory Society - ACO Registry

AstraZeneca.KK.0 个研究点目标入组 700 人开始时间: 2018年6月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients who participated in an intervention study such as a clinical trial within the last 8 weeks 2)Patients who is not appropriate for joining this study, judged by the investigators, due to the reasons such as they cannot comply with the procedures, restrictions and requirements of this study 3)Patients who experienced exacerbation of COPD or asthma within the last 8 weeks 4)Patients who have following diseases which cannot be distinguished from COPD or asthma at the time of obtaining consent: Diffuse panoramic bronchitis, congenital sinus bronchial syndrome, obstructive panbronchitis, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, lymphangiomyomatosis, interstitial lung disease, lung cancer, vocal fold dysfunction, intratracheal tumor, tracheal softening, bronchial tuberculosis, pulmonary thromboembolism, congestive heart failure

发起方

AstraZeneca.KK.